COVID-19 Anxiety Scale
The COVID‑19 Anxiety Scale screens for dysfunctional, COVID‑specific anxiety based on brief somatic symptoms.
Indications for Use
Used to screen physiologic anxiety responses specific to COVID‑19 and identify individuals with dysfunctional, impairing fear reactions. Appropriate for general populations, patients with chronic illness, or survivors of COVID‑19–related stressors. Demonstrates reliable unidimensional structure and good validity (e.g., α = 0.84; CAS‑BR psychometric study 1 [Level II evidence]). Clinically useful for brief triage, tracking pandemic‑related anxiety, and flagging those needing mental‑health referral.
Insights & Cautions
Identifies physiologic anxiety specific to COVID‑19 but captures only somatic fear responses, not generalized anxiety. Validation studies show good internal consistency (α ≈ 0.84) and unidimensional structure, though item strength varies by sex and age 1 [Level II evidence]. Scores correlate with generalized anxiety and depression but cut‑offs are imprecise (AUC 0.77; low Youden index). Use as a screening aid only; avoid overinterpreting as a diagnostic tool.